Amarin Corporation Plc (AMRN US)

Analysis

Health Care • United States

Amarin Corporation PLC develops, manufactures, and distributes biopharmaceutical therapeutics. The Company markets its products used in the treatment of cardiovascular diseases to healthcare providers, clinics, researchers, and facilities throughout the world.

Refresh

Focused

bullish•Nippon Suisan Kaisha

•14 Sep 2018 10:41

Nippon Suisan (1332)--Update on Amarin's Reduce-It Trial Data Scheduled for Release by Month-End

We recently published an Insight (Nippon Suisan (1332)--The Biggest Event in Japan's Food & Beverage Sector Comes Within 4 Weeks) on Japanese...

SC Capital

1.3k Views

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00